Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | DAO | P14920 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | NAAA | Q02083 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4761965 | 0.82 | LMNA (0.42) | LMNAMAPTALDH1A1CYP1A2MAPK1 | |
| SCHEMBL18360728 | 0.81 | MAPT (0.32) | MAPT | |
| SCHEMBL111175 | 0.80 | CYP1A2 (0.53) | LMNAMAPTALDH1A1CYP1A2 | |
| SCHEMBL4957551 | 0.79 | MAPT (0.43) | MAPTDAO | |
| SCHEMBL13464005 | 0.79 | MAPT (0.50) | LMNAMAPTCYP1A2DAOMAPK1 | |
| SCHEMBL15728707 | 0.78 | MAPT (0.36) | MAPTCYP1A2DAO | |
| SCHEMBL2668019 | 0.77 | LMNA (0.41) | LMNAMAPTALDH1A1CYP1A2MAPK1 | |
| SCHEMBL8570161 | 0.75 | CYP1A2 (0.54) | LMNAMAPTCYP1A2DAOMAPK1 | |
| SCHEMBL13082034 | 0.75 | CYP1A2 (0.54) | LMNAMAPTCYP1A2DAOMAPK1 | |
| SCHEMBL10999279 | 0.75 | CYP1A2 (0.55) | LMNAMAPTALDH1A1CYP1A2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2424829-B1 | OMEGA-CYCLOHEXYLALKAN-1-OLES AND USE THEREOF AS ANTIMICROBIAL ACTIVES TO COMBAT BODY ODOR | SYMRISE AG (DE) | 2015-01-07 | — | — | EP | disclosed |
| US-8623340-B2 | Omega-cyclohexylalkan-1-oles and use thereof as antimicrobial actives to combat body odor | SYMRISE AG (DE) | 2014-01-07 | — | — | US | disclosed |
| US-20120107258-A1 | OMEGA-CYCLOHEXYLALKAN-1-OLES AND USE THEREOF AS ANTIMICROBIAL ACTIVES TO COMBAT BODY ODOR | SYMRISE AG (DE) | 2012-05-03 | — | — | US | disclosed |
| WO-2009101216-A2 | OMEGA-CYCLOHEXYLALKAN-1-OLES AND USE THEREOF AS ANTIMICROBIAL ACTIVES TO COMBAT BODY ODOR | SYMRISE GMBH & CO. KG (DE) | 2009-08-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120107258-A1 | OMEGA-CYCLOHEXYLALKAN-1-OLES AND USE THEREOF AS ANTIMICROBIAL ACTIVES TO COMBAT BODY ODOR | ALOX12, ALOX15, ALOX15B | LMNA 3689/4885MAPT 4829/4885ALDH1A1 123/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.